CIBC Asset Management Inc Acquires 84 Shares of Zimmer Biomet Holdings, Inc. (ZBH)

CIBC Asset Management Inc raised its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 0.5% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 18,719 shares of the medical equipment provider’s stock after buying an additional 84 shares during the period. CIBC Asset Management Inc’s holdings in Zimmer Biomet Holdings were worth $2,404,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of ZBH. Chevy Chase Trust Holdings Inc. boosted its position in Zimmer Biomet Holdings by 3.7% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 175,789 shares of the medical equipment provider’s stock valued at $21,466,000 after buying an additional 6,217 shares in the last quarter. CENTRAL TRUST Co boosted its position in Zimmer Biomet Holdings by 13.0% in the first quarter. CENTRAL TRUST Co now owns 5,055 shares of the medical equipment provider’s stock valued at $617,000 after buying an additional 580 shares in the last quarter. Raymond James Trust N.A. boosted its position in Zimmer Biomet Holdings by 0.3% in the first quarter. Raymond James Trust N.A. now owns 8,985 shares of the medical equipment provider’s stock valued at $1,097,000 after buying an additional 31 shares in the last quarter. Creative Planning boosted its position in Zimmer Biomet Holdings by 26.2% in the first quarter. Creative Planning now owns 15,334 shares of the medical equipment provider’s stock valued at $1,872,000 after buying an additional 3,184 shares in the last quarter. Finally, Stock Yards Bank & Trust Co. boosted its position in Zimmer Biomet Holdings by 1.0% in the first quarter. Stock Yards Bank & Trust Co. now owns 66,000 shares of the medical equipment provider’s stock valued at $8,059,000 after buying an additional 637 shares in the last quarter. 82.84% of the stock is owned by institutional investors and hedge funds.

Zimmer Biomet Holdings, Inc. (ZBH) traded down 0.93% on Friday, hitting $111.38. The stock had a trading volume of 1,036,099 shares. The company’s 50 day moving average is $123.10 and its 200-day moving average is $121.18. Zimmer Biomet Holdings, Inc. has a 1-year low of $95.63 and a 1-year high of $133.49. The firm has a market capitalization of $22.52 billion, a price-to-earnings ratio of 31.72 and a beta of 1.20.

Zimmer Biomet Holdings (NYSE:ZBH) last posted its quarterly earnings data on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $2.10 by $0.02. The company had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.95 billion. Zimmer Biomet Holdings had a net margin of 9.12% and a return on equity of 16.70%. The business’s quarterly revenue was up 1.1% compared to the same quarter last year. During the same quarter last year, the business posted $2.02 EPS. On average, analysts forecast that Zimmer Biomet Holdings, Inc. will post $8.24 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 22nd will be given a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a dividend yield of 0.86%. The ex-dividend date is Thursday, September 21st. Zimmer Biomet Holdings’s dividend payout ratio (DPR) is currently 27.59%.

COPYRIGHT VIOLATION WARNING: “CIBC Asset Management Inc Acquires 84 Shares of Zimmer Biomet Holdings, Inc. (ZBH)” was posted by BNB Daily and is owned by of BNB Daily. If you are reading this piece on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.baseball-news-blog.com/2017/08/19/cibc-asset-management-inc-has-2-40-million-stake-in-zimmer-biomet-holdings-inc-zbh-updated.html.

Several equities analysts have commented on ZBH shares. Wells Fargo & Company cut Zimmer Biomet Holdings from an “outperform” rating to a “market perform” rating in a report on Friday, April 28th. Needham & Company LLC upped their price target on Zimmer Biomet Holdings from $151.00 to $153.00 and gave the company a “strong-buy” rating in a report on Friday, April 28th. Oppenheimer Holdings, Inc. set a $132.00 price target on Zimmer Biomet Holdings and gave the company a “buy” rating in a report on Friday, April 28th. Canaccord Genuity reaffirmed a “buy” rating on shares of Zimmer Biomet Holdings in a report on Friday, April 28th. Finally, Goldman Sachs Group, Inc. (The) started coverage on Zimmer Biomet Holdings in a report on Tuesday, May 16th. They issued a “sell” rating and a $92.00 price target for the company. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $136.90.

In related news, VP Tony W. Collins sold 16,986 shares of Zimmer Biomet Holdings stock in a transaction on Monday, July 31st. The shares were sold at an average price of $121.74, for a total value of $2,067,875.64. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Sang Yi sold 17,731 shares of Zimmer Biomet Holdings stock in a transaction on Monday, June 12th. The stock was sold at an average price of $124.56, for a total transaction of $2,208,573.36. The disclosure for this sale can be found here. Company insiders own 1.07% of the company’s stock.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply